2,664
Views
4
CrossRef citations to date
0
Altmetric
Review; Medical Biotechnology

Gene polymorphisms in periodontitis. Overview

, &
Pages 834-839 | Received 30 Jan 2015, Accepted 26 May 2015, Published online: 23 Jun 2015

References

  • Jepsen S, Eberhard J, Fricke D, et al. Interleukin-1 gene polymorphisms and experimental gingivitis. J Clin Periodontol. 2003;30:102–106.
  • Scapoli C, Tatakis DN, Mamolini E, et al. Modulation of clinical expression of plaque-induced gingivitis:interleukin-1 gene cluster polymorphisms. J Periodontol. 2005;76:49–56.
  • Tatakis DN, Trombelli L. Modulation of clinical expression of plaque-induced gingivitis. I. Background review and rationale. J Clin Periodontol. 2004;31:229–238.
  • Michalowicz BS, Diehl SR, Gunsolley JC, et al. Evidence of a substantial genetic basis for risk of adult periodontitis. J Periodontol.2000;71:1699–1707.
  • Schatzle M, Loe H, Burgin W, et al. Clinical course of chronic periodontitis. I. Role of gingivitis. J Clin Periodontol. 2003;30:887–901.
  • Schatzle M, Loe H, Lang NP, et al. The clinical course of chronic periodontitis. J Clin Periodontol. 2004;31:1122–1127.
  • Suda R, Cao C, Hasegawa K, et al. 2 years observation of attachment loss in a rural Chinese population. J Periodontol. 2000;71:1067–1072.
  • Trombelli L. Susceptibility to gingivitis: a way to predict periodontal disease? Oral Health Prev Dent. 2004;2(Suppl.1):265–269.
  • Dietrich T, Kaye EK, Nunn ME, et al. Gingivitis susceptibility and its relation to periodontitis in men. J Dent Res. 2006;85:1134–1137.
  • Kornman K, Crane A, Newman M, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol. 1997;24:72–77.
  • Gore A, Sanders J, Palesh Y, et al. Interleukin-1β+3953 allele 2: association with disease status in adult periodontitis. J Clin Periodontol. 1998;25:781–785.
  • Sugita N, Yamamoto K, Kobayashi T, et al. Revalence of FcγRIІІa-158V-F polymorphism to recurrence of adult periodontitis in Japanese patients. Clin Exp Immunol. 1999;117:350–354.
  • Duff GW. Molecular genetics of cytokines: cytokines in chronic inflammatory disease. In: Thompson A, editor. The cytokine handbook. 3rd ed. London: Academic Press; 1998. p. 21–33.
  • Duff GW. Molecular genetics of cytokines. In: Thomson A, editor. The cytokine handbook. 2nd ed. London: Academic Press; 1994. p. 21–30.
  • Duff W. Cytokines and anti-cytokines. Br J Rheumatol. 1993;32(Suppl.1):15–20.
  • Hart C, Kornman S. Genetic factors in the pathogenesis of periodontitis. Periodontol. 1997;14:202–215.
  • Suzuki A, Ji G, Numabe, Y, et al. Large scale investigation of genomic markers for severe periodontitis. Odontology. 2004; 92:43–47.
  • Waterer GW, Wunderink RG. Science review: genetic variability in the systemic inflammatory response. Crit Care. 2003;7:308–314.
  • Loos BG, John RP, Laine ML. Identification of genetic risk factors for periodontitis and possible mechanisms of action. J Clin Periodontol. 2005;32(Suppl.6):159–179.
  • Dongari-Bagtzoglou AI, Ebersole JL. Increased presence of interleukin-6 expression in the periodontium. J Periodontol. 1998;77:1871–1878.
  • Mlachkova A, Popova Chr, Kicheva M. IL-1B gene polymorphisms in conjunction with severity of chronic periodontitis. Probl Dent Med. 2011;37(1):6–14. Bulgarian.
  • D'Aiuto F, Parkar M, Brett PM, et al. Gene polymorphisms in pro-inflammatory cytokines are associated with systemic inflammation in patients with severe periodontal infections. Cytokine. 2004;28:29–34.
  • Takashiba S, Naruishi K, Murayama Y. Perspective of cytokine regulation for periodontal treatment: fibroblast biology. J Periodontol. 2003;74:103–110.
  • Laine ML, Loos BG, Crielaard W. Gene polymorphisms in chronic periodontitis. Int J Dent. 2010;2010:Article ID 324719. Available from: http://dx.doi.org/10.1155/2010/324719.
  • Karimbux NY, Saraiya VM, Elangovan S, et al. Interleukin-1 gene polymorphisms and chronic periodontitis in adult whites: a systematic review and meta-analysis. J Periodontol. 2012;83:1407–1419.
  • Nicklin H, Weith A, Duff W. A physical map of the region encompassing the human interleukin- 1 α, β and the interleukin - 1 receptor antagonist genes. Genomics. 1994;19:382–384.
  • Dinarello A. Biologic basis for interleukin-1 in disease. Blood. 1996;87:2095–2147.
  • Ishihara Y, Nishihara T, Shirozu N, et al. Gingival crevicular interleukin-1 receptor antagonist in periodontally healthy and diseased sites. J Periodontal Res. 1997;32:524–529.
  • Socransky SS, Haffajee AD, Smith C, et al. Microbiological parameters associated with IL-1 gene polymorphisms in periodontitis patients. J Clin Periodontol. 2000;27:810–818.
  • Walker SJ, Van Dyke TE, Rich S, et al. Genetic polymorphisms of the IL-1α and IL-1β genes in African–American LJP patients and an African-American control population. J Periodontol. 2000;71:723–728.
  • Armitage GC, Wu Y, Wang HY, et al. Low prevalence of a periodontitis-associated interleukin1 composite genotype in individuals of Chinese heritage. J Periodontol. 2000;71(2):164–171.
  • Wolf HF, Rateitschak EM, Rateitschak KH, et al. Genetic risk—Test for IL-1 gene polymorphism. In: Rateitschak KH, Wolf HF, editors. Color atlas of dental medicine: periodontology. 3rd ed. Stuttgart: Thieme; 2005. p. 189–191.
  • Pociot F, Molvig J, Wogensen L, et al. A Taq I polymorphism in the human interleukin-1β (IL- β) gene correlates with IL-1β secretion in vitro. Eur J Clin Investig. 1992;22:396–402.
  • Nikolopoulos GK, Dimou NL, Hamodrakas SJ, et al. Cytokine gene polymorphisms in periodontal disease: a meta-analysis of 53 studies including 4178 cases and 4590 controls. J Clin Periodontol. 2008;35:754–767.
  • Danis A, Millington M, Hyland J, et al. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1RA) gene polymorphism. Clinical Exp Immunol. 1995;99:303–310.
  • Hurme M, Santtila S. IL-1 receptor antagonist (IL-1RA) plasma level is coordinately regulated by both IL-1 RA and IL- 1β genes. Eur J Immunol. 1998;28:2598–2602.
  • Wu X, Offenbacher S, Lόpez NJ, et al. Association of interleukin-1 gene variations with moderate to severe chronic periodontitis in multiple ethnicities. J Periodontal Res. 2015;50:52–61.
  • Shih YS, Fu E, Martin M, et al. Association of CCL5 and CCR5 gene polymorphisms with periodontitis in Taiwanese. J Periodontol. 2014;85:1596–1602.
  • Kornman KS, Polverini PJ. Clinical application of genetics to guide prevention and treatment of oral diseases. Clin Genet. 2014;86(1):44–49.
  • Archana PM, Salman AA, Kumar TS, et al. Association between interleukin-1 gene polymorphism and severity of chronic periodontitis in a south Indian population group. J Indian Soc Periodontol. 2012;16(2):174–178.
  • Agrawal AA, Kapley A, Yeltiwar RK, et al. Assessment of single nucleotide polymorphism at IL-1A+4845 and IL-1B+3954 as genetic susceptibility test for chronic periodontitis in Maharashtrian ethnicity. J Periodontol. 2006;77(9):1515–1521.
  • López NJ, Jara L, Valenzuela CY. Association of interleukin-1 polymorphisms with periodontal disease. J Periodontol. 2005;76(2):234–243.
  • De Molon RS, De Avila ED, Nogueira AVB, et al. Evaluation of the host response in various models of induced periodontal disease in mice. J Periodontol. 2014;85:465–477.
  • Sánchez GS, Miozza VA, Delgado A, et al. Salivary IL-1β and PGE 2 as biomarkers of periodontal status, before and after periodontal treatment. J Clin Periodontol. 2013;40:1112–1117.
  • Holmes CL, Russell JA, Walley KR. Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. Chest. 2003;124:1103–1115.
  • Shimada Y, Tai H, Endo M, et al. Association of tumor necrosis factor receptor type 21587 gene polymorphism with severe chronic periodontitis. J Clin Periodontol. 2004;31:463–469.
  • Aguillon JC, Escobar A, Ferreira V, et al. Daily production of human tumor necrosis factor in lipopolysaccharide (LPS)-stimulated ex vivo blood culture assays. Eur Cytokine Netw. 2001;12:105–110.
  • Sykora J, Subrt I, Didek P, et al. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G→A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease. J Pediatr Gastroenterol Nutr. 2006;42:479–487.
  • Cucchiara S, Latiano A, Palmieri O, et al. Polymorphisms of tumor necrosis factor- alpha but not MDR1 influence response to medical therapy in pediatric-onset inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2007;44:171–179.
  • Fassmann A, Holla LI, Buckova D, et al. Polymorphisms in the 1252 (A/G) lymphotoxin alpha and the 308 (A/G) tumor necrosis factor-alpha genes and susceptibility to chronic periodontitis in a Czech population. J Periodontal Res. 2003;38:394–399.
  • Galbraith GM, Hendley TM, Sanders JJ, et al. Polymorphic cytokine genotypes as markers of disease severity in adult periodontitis. J Clin Periodontol. 1999;26:705–709.
  • Messer G, Spengler U, Jung MC, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med. 1991;173:209–219.
  • Heesen M, Kunz D, Bachmann-Mennenga B, et al. Linkage disequilibrium between tumor necrosis factor (TNF)-alpha -308 G/A promoter and TNF-beta NcoI polymorphisms: association with TNF-alpha response of granulocytes to endotoxin stimulation. Crit Care Med. 2003;31:211–214.
  • Majetschak M, Krehmeier U, Ostroverkh L, et al. Alterations in leukocyte function following surgical trauma: differentiation of distinct reaction types and association with tumor necrosis factor gene polymorphisms. Clin Diagn Lab Immunol. 2005;12:296–303.
  • Kornman KS, di Giovine FS. Genetic variations in cytokine expression: a risk factor for severity of adult periodontitis. Ann Periodontol. 1998;3(1):327–338.
  • Galbraith GM, Steed RB, Sanders JJ, et al. Tumor necrosis factor-alpha production by oral leukocytes: influence of tumor necrosis factor genotype. J Periodontol. 1998;69:428–433.
  • Scapoli C, Mamolini E, Trombelli L. Role of IL-6, TNF-A and LT-A variants in the modulation of the clinical expression of plaque-induced gingivitis. J Clin Periodontol. 2007;34:1031–1038.
  • Geivelis M, Turner DW, Pederson ED, et al. Measurements of interleukin-6 in gingival crevicular fluid from adults with destructive periodontal disease. J Periodontol. 1993;64:980–983.
  • Gabay G. Interleukin-6 and chronic inflammation. Arthritis Res Ther. 2006;8(Suppl.2):S3, doi:10.1186/ar1917.
  • Kishimoto T. Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res Ther. 2006;(Suppl.2):S2, doi:10.1186/1916.
  • Ishimi Y, Miyaura C, Jin CH, et al. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol. 1990;145:3297–3303.
  • Tamura T, Udakawa N, Takahashi N, et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci USA. 1993;90:11924–11928.
  • Ishihara K, Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 2002;13:357–368.
  • Kishimoto T. The biology of interleukin-6. Blood. 1989;74:1–10.
  • Takahashi K, Takashiba S, Nagai A, et al. Assessment of Serum IL-6 in the pathogenesis of periodontal disease. J Periodontol. 1994;65:147–153.
  • Guillot JL, Pollock SM, Johnson RB. Gingival interleukin-6 concentration following phase I therapy. J Periodontol. 1995;66:667–672.
  • McGee JM, Tucci MA, Edmundson TP, et al. The relationship between concentrations of proinflammatory cytokines within gingival and the adjacent sulcular depth. J Periodontol. 1998;69:865–871.
  • Reinhardt RA, Masada MP, Kaldahl WB, et al. Gingival fluid IL-1 and IL-6 levels in refractory periodontitis. J Clin Periodontol. 1993;20:225–231.
  • D' Aiuto F, Nibali L, Mohamed-Ali V, et al. Periodontal therapy: a novel non-drug-induced experimental model to study human inflammation. J Periodontal Res. 2004;39:294–299.
  • Forner L, Neilson CH, Bendtzen K, et al. Increased plasma levels of IL-6 in bacteremic periodontitis patients after scaling. J Clin Periodontol. 2006;33:724–729.
  • Ide M, Jagdev D, Coward PY, et al. The short-term effects of treatment of chronic periodontitis on circulating levels of endotoxin, C-reactive protein, tumor necrosis factor-a, and interleukin 6. J Periodontol. 2004;75:420–428.
  • D'Aiuto FD, Parkar M, Andreou G, et al. Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res. 2004;83:156–160.
  • Olomolaiye O, Wood NA, Bidwell JL. A novel NlaIII polymorphism in the human IL-6 promoter. Eur J Immunogenet.1998;25:267.
  • Shirodaria S, Smith J, McKay IJ, et al. Polymorphisms in the IL-1A gene are correlated with levels of interleukin-1alpha protein in gingival crevicular fluid of teeth with severe periodontal disease. J Dental Res. 2000;79:1864–1869.
  • Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA. 1997;94:3195–3199.
  • Tervonen T, Raunio T, Knuuttila M, et al. Polymorphisms in the CD14 and IL-6 genes associated with periodontal disease. J Clin Periodontol. 2007;34:377–383.
  • Raunio T, Nixdorf M, Knuuttila M, et al. The extent of periodontal disease and the IL-6-174 genotype as determinants of serum IL-6 level. J Clin Periodontol. 2007;34:1025–1030.
  • Morse HR, Olomolaiye OO, Wood NA, et al. Induced heteroduplex genotyping of TNF-alpha, IL-1beta, IL-6 and IL-10 polymorphisms associated with transcriptional regulation. Cytokine. 1999;11:789–795.
  • Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Investig. 1998;102:1369–1376.
  • Bouma G, Crusius JB, Oudkerk Pool M, et al. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol. 1996;43:456–463.
  • Pociot F, Briant L, Jongeneel CV, et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol. 1993;23:224–231.
  • Page RC. The pathobiology of periodontal diseases may affect systemic diseases: inversion of a paradigm. Ann Periodontol. 1998;3:108–120.